Unio Capital’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-135,823
Closed -$8.07M 57
2022
Q1
$8.07M Sell
135,823
-2,484
-2% -$159K 3.48% 15
2021
Q4
$783K Buy
138,307
+6,814
+5% +$469K 3.82% 15
2021
Q3
$9.19M Sell
131,493
-857
-0.6% -$60.2K 4.09% 11
2021
Q2
$9.11M Sell
132,350
-7,144
-5% -$477K 4.06% 10
2021
Q1
$9.02M Buy
139,494
+250
+0.2% +$16.1K 4.27% 10
2020
Q4
$8.11M Buy
139,244
+41,519
+42% +$2.51M 3.99% 13
2020
Q3
$5.94M Buy
97,725
+8,817
+10% +$611K 3.22% 17
2020
Q2
$6.84M Sell
88,908
-29,975
-25% -$2.3M 4.13% 10
2020
Q1
$8.89M Sell
118,883
-9,178
-7% -$634K 6.27% 4
2019
Q4
$8.32M Buy
128,061
+3,595
+3% +$234K 4.88% 7
2019
Q3
$7.89M Buy
124,466
+8,923
+8% +$583K 5.06% 8
2019
Q2
$7.92M Buy
115,543
+8,533
+8% +$561K 4.93% 8
2019
Q1
$6.96M Buy
107,010
+5,886
+6% +$391K 4.87% 8
2018
Q4
$6.33M Sell
101,124
-4,516
-4% -$316K 4.99% 7
2018
Q3
$8.16M Buy
105,640
+9,751
+10% +$736K 5.34% 7
2018
Q2
$6.79M Buy
95,889
+9,644
+11% +$681K 5.11% 7
2018
Q1
$6.5M Buy
86,245
+13,275
+18% +$1.06M 5.41% 6
2017
Q4
$5.23M Buy
+72,970
New +$5.54M 4.36% 8

Other funds holding GILD

Unio Capital's GILD Position: Q2 2022 in Review

Unio Capital sold out of Gilead Sciences (GILD) in Q2 2022, closing a stake of 135,823 shares — an estimated $8.07M sold.

Unio Capital first reported a position in GILD in Q4 2017 and held it in 18 quarters. The position peaked at $9.19M in Q3 2021. 1,604 funds tracked by Wall St. Rank hold GILD as of Q2 2022.

  • Unio Capital reported no remaining Gilead Sciences position as of Q2 2022 after selling out during the quarter.
  • Unio Capital sold 135,823 Gilead Sciences shares in Q2 2022, an estimated $8.07M.
  • Unio Capital first reported a position in Gilead Sciences in Q4 2017 and held it in 18 quarters.
  • Unio Capital's Gilead Sciences position peaked at $9.19M in Q3 2021.
  • 1,604 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2022.

Based on Unio Capital's 13F filing for Q2 2022, filed 15 Aug 2022.